These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 16136475)
1. Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium. Dann SM; Wang HC; Gambarin KJ; Actor JK; Robinson P; Lewis DE; Caillat-Zucman S; White AC J Infect Dis; 2005 Oct; 192(7):1294-302. PubMed ID: 16136475 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation. Zhang C; Zhang J; Niu J; Zhang J; Tian Z Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. Ostberg JR; Dayanc BE; Yuan M; Oflazoglu E; Repasky EA J Leukoc Biol; 2007 Nov; 82(5):1322-31. PubMed ID: 17711975 [TBL] [Abstract][Full Text] [Related]
5. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells. Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290 [TBL] [Abstract][Full Text] [Related]
6. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis]. Guo KY; Mei JZ; Yao KT Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia. Romanski A; Bug G; Becker S; Kampfmann M; Seifried E; Hoelzer D; Ottmann OG; Tonn T Exp Hematol; 2005 Mar; 33(3):344-52. PubMed ID: 15730858 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway. Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340 [TBL] [Abstract][Full Text] [Related]
9. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression. Song H; Kim J; Cosman D; Choi I Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603 [TBL] [Abstract][Full Text] [Related]
10. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels. Boyiadzis M; Memon S; Carson J; Allen K; Szczepanski MJ; Vance BA; Dean R; Bishop MR; Gress RE; Hakim FT Biol Blood Marrow Transplant; 2008 Mar; 14(3):290-300. PubMed ID: 18275895 [TBL] [Abstract][Full Text] [Related]
12. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species. Romero AI; Thorén FB; Brune M; Hellstrand K Br J Haematol; 2006 Jan; 132(1):91-8. PubMed ID: 16371024 [TBL] [Abstract][Full Text] [Related]
13. The expression of human natural killer cell receptors in early life. Sundström Y; Nilsson C; Lilja G; Kärre K; Troye-Blomberg M; Berg L Scand J Immunol; 2007; 66(2-3):335-44. PubMed ID: 17635811 [TBL] [Abstract][Full Text] [Related]
14. Telomere length in human natural killer cell subsets. Ouyang Q; Baerlocher G; Vulto I; Lansdorp PM Ann N Y Acad Sci; 2007 Jun; 1106():240-52. PubMed ID: 17303822 [TBL] [Abstract][Full Text] [Related]
15. A protective role for interleukin 18 in interferon γ-mediated innate immunity to Cryptosporidium parvum that is independent of natural killer cells. Choudhry N; Petry F; van Rooijen N; McDonald V J Infect Dis; 2012 Jul; 206(1):117-24. PubMed ID: 22517912 [TBL] [Abstract][Full Text] [Related]
16. The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells. Baeriswyl V; Wodnar-Filipowicz A; Kalberer CP Haematologica; 2006 Nov; 91(11):1538-41. PubMed ID: 17043026 [TBL] [Abstract][Full Text] [Related]
17. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681 [TBL] [Abstract][Full Text] [Related]
18. IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway. Song H; Hur DY; Kim KE; Park H; Kim T; Kim CW; Bang S; Cho DH Cell Immunol; 2006 Jul; 242(1):39-45. PubMed ID: 17070508 [TBL] [Abstract][Full Text] [Related]
19. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210 [TBL] [Abstract][Full Text] [Related]
20. MHC class I chain-related molecules induced on monocytes by IFN-gamma promote NK cell activation. Wang H; Ruan Z; Wang Y; Han J; Fu X; Zhao T; Yang D; Xu W; Yang Z; Wang L; Chen Y; Wu Y Mol Immunol; 2008 Mar; 45(6):1548-56. PubMed ID: 18062910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]